Sökning: "cardiovascular factors"

Visar resultat 36 - 40 av 964 avhandlingar innehållade orden cardiovascular factors.

1. 36. Obesity in diabetes. Cardiovascular outcomes and risk factor trajectories

   Författare :Jon Edqvist; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; type 1 diabetes mellitus; type 2 diabetes mellitus; body mass index; cardiovascular disease; epidemiology; reverse causality; mortality; heart failure; myocardial infarction; trajectories; machine learning;

   Sammanfattning : Introduction: The association between body mass index (BMI) and mortality in diabetes is complex and sparsely investigated for cardiovascular (CVD) outcomes. We aimed to investigate these relationships among patients with type 1 and type 2 diabetes using data from the Swedish national diabetes registry (NDR), with focus on potential reverse causality. LÄS MER

3. 37. Coronary Heart Disease and Erectile Dysfunction

   Författare :Rasmus Borgquist; Kardiologi; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; risk factors; Cardiovascular system; Kardiovaskulära systemet; Erectile dysfunction; coronary heart disease;

   Sammanfattning : Coronary heart disease (CHD) is a common condition associated with a high mortality. There is now growing evidence that erectile dysfunction (ED) in men may be a suitable marker of sub-clinical cardiovascular disease, identifying patients at high risk for future CHD. LÄS MER

4. 38. Cardiovascular disease and hypertension : Population-based studies on self-rated health and health-related quality of life in Sweden

   Författare :Carola Bardage; Uppsala universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Pharmacy; Cardiovascular disease; hypertension; antihypertensive treatment; side effects; self-rated health; health-related quality of life; health-state utilities; SF-36 Health Survey; rating scale; time trade-off; general population; twins; FARMACI; PHARMACY; FARMACI; Social Pharmacy; samhällsfarmaci;

   Sammanfattning : The aim with this thesis was to study cardiovascular disease and hypertension, use of drugs and health from an epidemiological perspective. Various methods - self-rated health (SRH), health related quality of life (HRQL) - the 36-item short form questionnaire (SF-36) - and health utility measurements - the rating scale (RS) and the time-trade off (TTO) methods - were employed. LÄS MER

5. 39. Cardiovascular morbidity and metabolic signature in patients with rheumatoid arthritis

   Författare :Mitra Nadali; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Cardiovascular mortality; Rheumatoid arthritis; metabolic signature;

   Sammanfattning : Background and objectives: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease with excess risk for cardiovascular morbidity and mortality. The treatment of RA by anti-inflammatory drugs has dramatically been improved over the resent decades. LÄS MER

7. 40. Effects of gastric bypass surgery in patients with obesity and type 2 diabetes

   Författare :Vasileios Liakopoulos; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; gastric bypass; bariatric surgery; obesity; type 2 diabetes mellitus; cardiovascular disease; mortality; risk factors; renal disease; adverse events;

   Sammanfattning : Background: The effects of Roux-en-Y gastric bypass (GBP) have not been adequately explored in patients with concurrent obesity and type 2 diabetes mellitus (T2DM) to the same extent as has occurred for individuals with obesity alone. The overall aim of this thesis is to thoroughly examine the effects of GBP surgery in patients with obesity and T2DM in terms of cardiovascular disease and mortality, changes in various comorbidities, risk factors, and renal function as well as reporting adverse events. LÄS MER